Orticumab (Anti-oxLDL)
A2386
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NameOrticumab (Anti-oxLDL)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionOrticumab (MLDL1278A) is an antibody targeting oxidized or malondialdehyde-modified lipoprotein (LDL) that specifically inhibits oxidised low-density lipoproteins (oxLDL). Orticumab is involved in the modulation of autoimmune responses against oxLDL and improves atherosclerosis in an animal model. MW: 145.5 kD.
- Storage Instruction-20°C
- UNSPSC12352203